Table 2.
Saturated, monounsaturated and polyunsaturated fatty acids, across group of baseline NCV
| NCV (<40 m/s), (n = 129) | NCV (40–42 m/s), (n = 206) | NCV (>42 m/s), (n = 906) | Beta + SE | P* | |
|---|---|---|---|---|---|
| Saturated fatty acids (%) | 32.4 ± 3.1 | 32.8 ± 2.9 | 32.3 ± 2.8 | 0.06 ± 0.04 | 0.11 |
| Monounsaturated fatty acids (%) | 32.4 ± 3.3 | 31.2 ± 3.8 | 30.2 ± 3.8 | −0.03 ± 0.03 | 0.33 |
| Polyunsaturated fatty acids (%) | 35.2 ± 4.6 | 36.0 ± 5.0 | 37.5 ± 4.9 | 0.005 ± 0.02 | 0.83 |
| Omega-6 fatty acids(mg/l) | 963.5 ± 220.0 | 1004.1 ± 232.0 | 1079.7 ± 237.0 | 0.001 ± 0.0005 | 0.002 |
| Linoleic acid (mg/l) | 720.3 ± 166.8 | 755.5 ± 179.6 | 813.0 ± 180.9 | 0.002 ± 0.006 | 0.002 |
| Arachidonic acid (mg/l) | 239.8 ± 73.4 | 245.2 ± 75.4 | 262.8 ± 83.0 | 0.003 ± 0.001 | 0.06 |
| Omega-3 fatty acids (mg/l) | 105.1 ± 39.1 | 101.4 ± 38.5 | 110.7 ± 41.8 | 0.36 ± 0.28 | 0.21 |
| Linolenic acid (mg/l) | 14.7 ± 10.8 | 13.9 ± 9.4 | 15.0 ± 9.3 | 0.008 ± 0.01 | 0.47 |
| Eicosapentaenoic acid (mg/l) | 19.5 ± 8.3 | 18.8 ± 8.1 | 20.0 ± 8.7 | 0.018 ± 0.01 | 0.15 |
| Docosahexaenoic acid (mg/l) | 70.9 ± 27.9 | 68.7 ± 27.8 | 75.7 ± 31.2 | 0.003 ± 0.004 | 0.37 |
| Ratio n-6/n-3 | 10.0 ± 2.3 | 10.8 ± 3.1 | 10.6 ± 3.1 | 0.02 ± 0.04 | 0.54 |
Values are given as mean ± SD.
*
General linear model with nerve conduction velocity (NCV) considered as a continous variable and adjusted for age, sex, body mass index, total cholesterol, triglycerides, diabetes and peripheral artery disease.